$2.02
4.27% today
Nasdaq, Apr 04, 10:00 pm CET
ISIN
US83558L1052
Symbol
SNOA
Sector
Industry

Sonoma Pharmaceuticals, Inc. Stock price

$2.02
-0.09 4.27% 1M
-0.76 27.34% 6M
-0.67 24.91% YTD
-1.19 36.99% 1Y
-69.38 97.17% 3Y
-107.98 98.16% 5Y
-717.98 99.72% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-0.09 4.27%
ISIN
US83558L1052
Symbol
SNOA
Sector
Industry

Key metrics

Market capitalization $3.41m
Enterprise Value $-1.71m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales -0.12
P/S ratio (TTM) P/S ratio 0.24
P/B ratio (TTM) P/B ratio 0.70
Revenue growth (TTM) Revenue growth 13.51%
Revenue (TTM) Revenue $13.97m
EBIT (operating result TTM) EBIT $-4.46m
Free Cash Flow (TTM) Free Cash Flow $130.00k
Cash position $5.24m
EPS (TTM) EPS $-3.93
P/S forward 0.25
EV/Sales forward negative
Short interest 14.16%
Show more

Is Sonoma Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Sonoma Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Sonoma Pharmaceuticals, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Sonoma Pharmaceuticals, Inc.:

Buy
100%

Financial data from Sonoma Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
14 14
13% 13%
100%
- Direct Costs 8.95 8.95
15% 15%
64%
5.03 5.03
11% 11%
36%
- Selling and Administrative Expenses 7.53 7.53
8% 8%
54%
- Research and Development Expense 1.81 1.81
9% 9%
13%
-4.32 -4.32
5% 5%
-31%
- Depreciation and Amortization 0.15 0.15
56% 56%
1%
EBIT (Operating Income) EBIT -4.46 -4.46
1% 1%
-32%
Net Profit -3.75 -3.75
26% 26%
-27%

In millions USD.

Don't miss a Thing! We will send you all news about Sonoma Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sonoma Pharmaceuticals, Inc. Stock News

Neutral
Accesswire
25 days ago
BOULDER, CO / ACCESS Newswire / March 10, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the registra...
Neutral
Accesswire
about one month ago
BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it w...
Neutral
Accesswire
about 2 months ago
Revenues increased 14% for the quarter compared to prior year and 13% year-to-date Positive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024 Year-to-date net loss decline of $1.1 million BOULDER, CO / ACCESS Newswire / February 5, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing stabilized hypochlorous...
More Sonoma Pharmaceuticals, Inc. News

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.

Head office United States
CEO Amy Trombly
Employees 172
Founded 1999
Website www.sonomapharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today